Literature DB >> 28271657

DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Shi-Yuan Hong1.   

Abstract

The DNA damage response (DDR) is activated when DNA is altered by intrinsic or extrinsic agents. This pathway is a complex signaling network and plays important roles in genome stability, tumor transformation, and cell cycle regulation. Human papillomaviruses (HPVs) are the main etiological agents of cervical cancer. Cervical cancer ranks as the fourth most common cancer among women and the second most frequent cause of cancer-related death worldwide. Over 200 types of HPVs have been identified and about one third of these infect the genital tract. The HPV life cycle is associated with epithelial differentiation. Recent studies have shown that HPVs deregulate the DDR to achieve a productive life cycle. In this review, I summarize current findings about how HPVs mediate the ataxia-telangiectasia mutated kinase (ATM) and the ATM-and RAD3-related kinase (ATR) DDRs, and focus on the roles that ATM and ATR signalings play in HPV viral replication. In addition, I demonstrate that the signal transducer and activator of transcription-5 (STAT)-5, an important immune regulator, can promote ATM and ATR activations through different mechanisms. These findings may provide novel opportunities for development of new therapeutic targets for HPV-related cancers.

Entities:  

Keywords:  ATM/CHK2; ATR/CHK1; Amplification; DNA damage; Differentiation; Papillomavirus; STAT-5

Mesh:

Substances:

Year:  2017        PMID: 28271657      PMCID: PMC5369246          DOI: 10.1631/jzus.B1600306

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  192 in total

1.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

Review 2.  DNA damage checkpoints in stem cells, ageing and cancer.

Authors:  Tobias Sperka; Jianwei Wang; K Lenhard Rudolph
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09       Impact factor: 94.444

3.  The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair.

Authors:  Claus Storgaard Sørensen; Lasse Tengbjerg Hansen; Jaroslaw Dziegielewski; Randi G Syljuåsen; Cecilia Lundin; Jiri Bartek; Thomas Helleday
Journal:  Nat Cell Biol       Date:  2005-01-23       Impact factor: 28.824

Review 4.  The role of Stat5 transcription factors as tumor suppressors or oncogenes.

Authors:  G Ferbeyre; R Moriggl
Journal:  Biochim Biophys Acta       Date:  2010-10-20

5.  Nuclear import strategies of high risk HPV16 L1 major capsid protein.

Authors:  Lisa M Nelson; Robert C Rose; Junona Moroianu
Journal:  J Biol Chem       Date:  2002-04-23       Impact factor: 5.157

6.  Human papillomavirus E7 induces rereplication in response to DNA damage.

Authors:  Xueli Fan; Yingwang Liu; Susan A Heilman; Jason J Chen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

7.  The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes.

Authors:  Atasi Poddar; Shawna C Reed; Maria G McPhillips; Jonathan E Spindler; Alison A McBride
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

Review 8.  The DNA damage response and cancer therapy.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

9.  Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.

Authors:  Heather L Howie; Jennifer I Koop; Joleen Weese; Kristin Robinson; Greg Wipf; Leslie Kim; Denise A Galloway
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

10.  Chemical genetics reveals a specific requirement for Cdk2 activity in the DNA damage response and identifies Nbs1 as a Cdk2 substrate in human cells.

Authors:  Lara Wohlbold; Karl A Merrick; Saurav De; Ramon Amat; Jun Hyun Kim; Stéphane Larochelle; Jasmina J Allen; Chao Zhang; Kevan M Shokat; John H J Petrini; Robert P Fisher
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

View more
  8 in total

Review 1.  Effects of β-HPV on DNA damage response pathways to drive carcinogenesis: a review.

Authors:  Danyal Tahseen; Peter L Rady; Stephen K Tyring
Journal:  Virus Genes       Date:  2021-01-03       Impact factor: 2.332

2.  Tissue-Specific Gene Expression during Productive Human Papillomavirus 16 Infection of Cervical, Foreskin, and Tonsil Epithelium.

Authors:  Sreejata Chatterjee; Sa Do Kang; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Willard Freeman; Craig Meyers
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

3.  The DNA damage response activates HPV16 late gene expression at the level of RNA processing.

Authors:  Kersti Nilsson; Chengjun Wu; Naoko Kajitani; Haoran Yu; Efthymios Tsimtsirakis; Lijing Gong; Ellenor B Winquist; Jacob Glahder; Lars Ekblad; Johan Wennerberg; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2018-06-01       Impact factor: 16.971

4.  Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.

Authors:  Shiyuan Hong; Junfen Xu; Yan Li; Jorge Andrade; Paul Hoover; Paul J Kaminski; Laimonis A Laimins
Journal:  Oncogene       Date:  2019-01-10       Impact factor: 9.867

5.  HPV infection associated DNA damage correlated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.

Authors:  Jin Zhao; Zhong Guo; Qiang Wang; Tianbin Si; Shuyan Pei; Hongmei Qu; Lina Shang; Yuqing Yang; Lili Wang
Journal:  Cancer Manag Res       Date:  2019-07-30       Impact factor: 3.989

Review 6.  Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.

Authors:  Kersti Nilsson; Chengjun Wu; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

7.  Synergistic Carcinogenesis of HPV18 and MNNG in Het-1A Cells through p62-KEAP1-NRF2 and PI3K/AKT/mTOR Pathway.

Authors:  Ying Zhang; Yue Ma; Chao Zhao; Hu Zhang; Yuepu Pu; Lihong Yin
Journal:  Oxid Med Cell Longev       Date:  2020-10-09       Impact factor: 6.543

8.  Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway.

Authors:  Shiyuan Hong; Yan Li; Paul J Kaminski; Jorge Andrade; Laimonis A Laimins
Journal:  mBio       Date:  2020-08-12       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.